← Open Payments lookup

RAGHAVENDRA SIRAGAVARAPU: Open Payments

NPI 1154582377 · CHERRY HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,043 in 56 payments from 16 companies in 2025. Trend: 2023 $45 · 2024 $593 · 2025 $1,043

Food & beverage: $1,043
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.5$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$148
ABBVIE INC.10$139
Vertical Pharmaceuticals, LLC4$101
Corium, LLC5$81
Supernus Pharmaceuticals, Inc.5$79
Janssen Pharmaceuticals, Inc3$55
Collegium Pharmaceutical, Inc.3$53
Neos Therapeutics, LP3$50
Otsuka America Pharmaceutical, Inc.3$46

Products named: COBENFY, CAPLYTA, VRAYLAR, Relexxii, Azstarys, Qelbree, REXULTI, SPRAVATO.

Industry payments across NJ — which companies pay providers there.